Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tabone

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Gastroenterology|July 1, 1996
Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholicsP Clot, E Albano, E Eliasson, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1997
Pre-treatment levels of anti-HCV core IgM antibodies are closely associated with response to alpha interferon therapy in chronic hepatitis C patientsM Tabone, P Secreto, C Marini, et al.
Gastroenterology|July 1, 1997
Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcoholP Clot, M Parola, G Bellomo, et al.
Revue D'Epidemiologie Et De Sante Publique|January 1, 1991
A case-control study on alcohol consumption and the risk of chronic liver diseaseG Corrao, S Arico, F Carle, et al.
Molecular Pharmacology|March 1, 1997
Genetic polymorphism of human CYP2E1: characterization of two variant allelesY Hu, M Oscarson, I Johansson, et al.
Clinical Immunology and Immunopathology|April 1, 1985
Presence and origin of IgA1- and IgA2-containing circulating immune complexes in chronic alcoholic liver diseases with and without glomerulonephritisR Coppo, S Aricò, G Piccoli, et al.
Journal of Viral Hepatitis|June 26, 2002
Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapyM Tabone, L Sidoli, C Laudi, et al.
Journal of Hepatology|October 30, 2001
Interferon and amantadine in combination as initial treatment for chronic hepatitis C patientsM Tabone, C Laudi, B Delmastro, et al.
Italian Journal of Gastroenterology and Hepatology|June 1, 1997
Gastrectomy, lack of gastric first pass metabolism of ethanol and alcoholic liver disease. Results of a multicentre studyM Frezza, A Buda, M M Terpin, et al.
Journal of Viral Hepatitis|April 12, 2000
Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre studyG Saracco, R Sostegni, V Ghisetti, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Gastroenterology|July 1, 1996
Cytochrome P4502E1 hydroxyethyl radical adducts as the major antigen in autoantibody formation among alcoholicsP Clot, E Albano, E Eliasson, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1997
Pre-treatment levels of anti-HCV core IgM antibodies are closely associated with response to alpha interferon therapy in chronic hepatitis C patientsM Tabone, P Secreto, C Marini, et al.
Gastroenterology|July 1, 1997
Plasma membrane hydroxyethyl radical adducts cause antibody-dependent cytotoxicity in rat hepatocytes exposed to alcoholP Clot, M Parola, G Bellomo, et al.
Revue D'Epidemiologie Et De Sante Publique|January 1, 1991
A case-control study on alcohol consumption and the risk of chronic liver diseaseG Corrao, S Arico, F Carle, et al.
Molecular Pharmacology|March 1, 1997
Genetic polymorphism of human CYP2E1: characterization of two variant allelesY Hu, M Oscarson, I Johansson, et al.
Clinical Immunology and Immunopathology|April 1, 1985
Presence and origin of IgA1- and IgA2-containing circulating immune complexes in chronic alcoholic liver diseases with and without glomerulonephritisR Coppo, S Aricò, G Piccoli, et al.
Journal of Viral Hepatitis|June 26, 2002
Alcohol abstinence does not offset the strong negative effect of lifetime alcohol consumption on the outcome of interferon therapyM Tabone, L Sidoli, C Laudi, et al.
Journal of Hepatology|October 30, 2001
Interferon and amantadine in combination as initial treatment for chronic hepatitis C patientsM Tabone, C Laudi, B Delmastro, et al.
Italian Journal of Gastroenterology and Hepatology|June 1, 1997
Gastrectomy, lack of gastric first pass metabolism of ethanol and alcoholic liver disease. Results of a multicentre studyM Frezza, A Buda, M M Terpin, et al.
Journal of Viral Hepatitis|April 12, 2000
Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C: correlation with clinical, virological and histological parameters. Results of a prospective multicentre studyG Saracco, R Sostegni, V Ghisetti, et al.
Pageof 4